Skip to content
Home
Our Science
Pipeline & Assets
Team & Investors
Careers
News & Resources
Connect
News
& Resources
Featured Stories
GlobeNewswire
Siren Biotechnology Named Innovator of the Year in 2026 BioTech Breakthrough Awards
Read More
GlobeNewswire
Siren Biotechnology Appoints Former FDA CBER Oncology Branch Chief to Clinical and Scientific Advisory Board
Read More
Endpoints News
Siren CEO named as a 2026 Endpoints News Women in Biopharma
Read More
News
Patient Resources
Videos
Publications & Presentations
All
Media Coverage
Press Releases
Media Coverage
|
Posted on 9.26.25
Siren Biotechnology named a 2025 Most Fundable Company
Read More
Press Releases
|
Posted on 5.12.25
Siren Biotechnology to Present Universal AAV Immuno-Gene Therapy Data at the 2025 American Society of Gene and Cell Therapy (ASGCT) Annual Meeting
Read More
Media Coverage
|
Posted on 5.11.25
Siren, a gene therapy startup, tests unconventional alternative to venture funding
Read More
Media Coverage
|
Posted on 5.10.25
Signal Alert: Startup Seeks Community Funders for AAV Immuno-Gene Therapy
Read More
Media Coverage
|
Posted on 4.16.25
Siren community investment round featured in BiotechTV
Read More
Media Coverage
|
Posted on 4.16.25
Siren Biotechnology Opens Community Investment Round!
Read More
Media Coverage
|
Posted on 4.3.25
Siren CEO and Founder Dr. Nicole Paulk named in SFBT Women to Watch
Read More
Media Coverage
|
Posted on 4.3.25
Siren Biotechnology Presents at SXSW 2025
Read More
Press Releases
|
Posted on 3.4.25
Siren Biotechnology Expands Clinical and Scientific Advisory Board with Key Industry Leaders
Read More
Media Coverage
|
Posted on 1.9.25
Siren Biotechnology named 2025 Company to Watch by Slice of Healthcare
Read More
1
2
3
4
…
6